Skip to main content
Earnings Labs
CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc. (CTMX)

NASDAQ·Healthcare·Biotechnology

$3.29

-1.79%

Mkt Cap $729.30M

Analyst Ratings

Buy

8

Hold

0

Sell

0

Price Target (22 analysts)

$11.00

Range $6.00$16.00

Implied Upside

+234.3%

Consensus $11.00 vs current $3.29